Title

Nasal Spray With Glucose Oxidase Preventing Common Cold in Pre-school Children
Placebo Controlled Study Among Children Below Four Years of Age, Investigating Whether a Glucose Oxidase Nasal Spray Can Reduce Days With Upper Respiratory Tract Infection Symptoms
  • Phase

    Phase 2
  • Study Type

    Interventional
  • Study Participants

    40
To investigate if use of glucosoxidas nasal spray can reduce the number of days with upper respiratory tract infections in children beyond 4 years.
Children below 4 years of age and in public day care were invited to participate in this prospective study. The children started with a visit to an ENT doctor and after inclusion the children started to spray twice daily with glucose oxidase+glucose or only saline+glucose for 3 months. During this period the parents were asked to fill in a home protocol recording upper respiratory tract symptoms as: rhinitis, cough, fever, ear ache. After 6 weeks and 12 weeks the children had scheduled visits to the ENT department, where an ENT doctor examined the throat, nasal cavity and the ear drums for otitis media. After 12 weeks of treatment a nasopharyngeal swab was taken for bacterial culture.
Study Started
Oct 31
2012
Primary Completion
May 31
2013
Study Completion
Jun 30
2013
Results Posted
Jan 11
2016
Estimate
Last Update
Jan 11
2016
Estimate

Drug Placebo

placebo containing saline+glucose

  • Other names: Baxter Rehydrex

Drug Glucose oxidase

a hydrogen peroxide producing enzyme that creates an acidous environment to which rhinoviruses are sensitive.

  • Other names: G2133, Sigmaaldrich

Placebo: Saline+glucose nasal spray Placebo Comparator

Subjects received nasal spray containing both saline+glucose twice daily for 3 months

Nasal spray with glucose oxidase+glucose Active Comparator

Nasal spray in a bag-on-valve device with 50U/ml containing both glucose oxidase + 5% glucose in isotone saline. Dosage: One puff in each nostril twice daily for 3 months.

Criteria

Inclusion Criteria:

Children below 4 years of age

Exclusion Criteria:

None

Summary

Saline+Glucose Nasal Spray

Nasal Spray With Glucose Oxidase+Glucose

All Events

Event Type Organ System Event Term Saline+Glucose Nasal Spray Nasal Spray With Glucose Oxidase+Glucose

Respiratory Infectious Symptoms

Days with upper respiratory tract infection symptoms during a 3 months period are recorded in a home protocol by the parents of the children.

Saline+Glucose Nasal Spray

Days with cough and rhinitis

6.0
days (Mean)
Standard Deviation: 5

days with fever

3.0
days (Mean)
Standard Deviation: 3

Days with rhinitis

10.0
days (Mean)
Standard Deviation: 6

Days with URTI

9.0
days (Mean)
Standard Deviation: 4

Nasal Spray With Glucose Oxidase+Glucose

Days with cough and rhinitis

8.0
days (Mean)
Standard Deviation: 6

days with fever

5.0
days (Mean)
Standard Deviation: 4

Days with rhinitis

13.0
days (Mean)
Standard Deviation: 10

Days with URTI

13.0
days (Mean)
Standard Deviation: 10

Total

40
Participants

Age, Continuous

28
months (Mean)
Full Range: 11.0 to 44.0

Age, Categorical

Region of Enrollment

Sex: Female, Male

Overall Study

Saline+Glucose Nasal Spray

Nasal Spray With Glucose Oxidase+Glucose